Nathan Ebstein
Overview
Explore the profile of Nathan Ebstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tandjaoui-Lambiotte Y, Elabbadi A, Marouane B, Besset S, Roux D, Ebstein N, et al.
J Infect Public Health
. 2024 Jun;
17(8):102454.
PMID: 38936235
Background: The risk of SARS-CoV-2 transmission to health care workers in intensive care units (ICU) and the contribution of airborne and fomites to SARS-CoV-2 transmission remain unclear. To assess the...
2.
Pichon J, Roche A, Fauvel C, Boucly A, Mercier O, Ebstein N, et al.
Eur Heart J Cardiovasc Imaging
. 2023 May;
24(11):1518-1527.
PMID: 37194564
Aims: We aim to evaluate the clinical relevance and the prognostic value of arterial and venous renal Doppler in acute decompensated precapillary pulmonary hypertension (PH). Methods And Results: The renal...
3.
Beurnier A, Savale L, Jais X, Colle R, Pham T, Morin L, et al.
ERJ Open Res
. 2023 May;
9(3).
PMID: 37131523
Background: Dyspnoea is a common persistent symptom after COVID-19. Whether it is associated with functional respiratory disorders remains unclear. Methods: We assessed the proportion and characteristics of patients with "functional...
4.
Certain M, Baron A, Turpin M, Ebstein N, Boucly A, Beurnier A, et al.
Eur Respir J
. 2022 Jun;
60(2).
PMID: 35680147
No abstract available.
5.
Montani D, Certain M, Weatherald J, Jais X, Bulifon S, Noel-Savina E, et al.
Am J Respir Crit Care Med
. 2022 May;
206(5):573-583.
PMID: 35549842
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with pulmonary endothelial dysfunction. There are limited data available on the outcomes of coronavirus disease (COVID-19) in patients with pulmonary...
6.
Savale L, Vuillard C, Pichon J, Boucly A, Roche A, Jevnikar M, et al.
Eur Respir J
. 2021 Jun;
58(3).
PMID: 34083404
No abstract available.
7.
Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, et al.
Ann Intensive Care
. 2021 Feb;
11(1):37.
PMID: 33638752
Background: The efficacy of high flow nasal canula oxygen therapy (HFNO) to prevent invasive mechanical ventilation (IMV) is not well established in severe coronavirus disease 2019 (COVID-19). The aim of...
8.
Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al.
J Hepatol
. 2020 Sep;
73(5):1293-1294.
PMID: 32907706
No abstract available.
9.
Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al.
J Hepatol
. 2020 Mar;
73(1):130-139.
PMID: 32145258
Background & Aims: Long-term outcomes in portopulmonary hypertension (PoPH) are poorly studied in the current era of pulmonary hypertension management. We analysed the effect of pulmonary arterial hypertension (PAH)-targeted therapies,...